PR069/#709  Prognostic impact of erythropoietin-stimulating agents during front-line chemotherapy in patients with ovarian cancer: a Korean multicenter cohort study

Seung-Hyuk Shim; Eunbi Jang; Eun Jung Yang; Hee Seung Kim; Shin Wha Lee; Sung Jong Lee; Suk-Joon Chang; Myong Cheol Lim; Chel Hun Choi

doi:10.1136/ijgc-2023-IGCS.109

Article info

Featured Posters: Poster Rounds with the Professors

AS11. Ovarian cancer

PR069/#709 Prognostic impact of erythropoietin-stimulating agents during front-line chemotherapy in patients with ovarian cancer: a Korean multicenter cohort study

Free

Authors

Seung-Hyuk Shim Konkuk University Hospital, Obstetrics and Gynecology, Seoul, Korea, Republic of PubMed articles Google scholar articles
Eunbi Jang Konkuk University School of Medicine, Obstetrics and Gynecology, Seoul, Korea, Republic of PubMed articles Google scholar articles
Eun Jung Yang Konkuk University School of Medicine, Obstetrics and Gynecology, Seoul, Korea, Republic of PubMed articles Google scholar articles
Hee Seung Kim Seoul National University College of Medicine, Obstetrics and Gynecology, Seoul, Korea, Republic of PubMed articles Google scholar articles
Shin Wha Lee Asan Medical Center, Department of Obstetrics and Gynecology, Seoul, Korea, Republic of PubMed articles Google scholar articles
Sung Jong Lee Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Obstetrics and Gynecology, Seoul, Korea, Republic of PubMed articles Google scholar articles
Suk-Joon Chang Ajou University Medical Center, Obstetrics and Gynecology, Suwon, Korea, Republic of PubMed articles Google scholar articles
Myong Cheol Lim Center for Gynecologic Cancer, National Cancer Center, Department of Obstetrics and Gynecology, Goyang, Korea, Republic of PubMed articles Google scholar articles
Chel Hun Choi Samsung Medical Center, Department of Obstetrics and Gynecology, Seoul, Korea, Republic of PubMed articles Google scholar articles

Citation

Shim S, Jang E, Yang EJ, et al

PR069/#709 Prognostic impact of erythropoietin-stimulating agents during front-line chemotherapy in patients with ovarian cancer: a Korean multicenter cohort study

International Journal of Gynecologic Cancer 2023;33:A70.

Publication history

First published November 7, 2023.

Online issue publication

November 07, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password